📈 New Trade Recommendation Buy: ZYDUSLIFE-EQ Range: 912 - 920 Target: 990 Stop Loss: 901 CMP: 918.9 Risk Reward Ratio: 1:4.0 🖊️ Notes: Rational - Good results posted by the company and Positive Guidance by Management - FY25 Revenue & Profitability: Consolidated revenues of ₹232.4 bn (+19% YoY). EBITDA of ₹70.6 bn (+31% YoY); EBITDA margin at 30.4% (+290 bps YoY, highest ever). Net profit (excl. exceptionals) at ₹47.5 bn (+22% YoY). Net cash position: ₹48.8 bn as of Mar’25 vs ₹8.6 bn in Mar’24—a significant strengthening of the balance sheet. Q4 FY25 Outperformance: Revenue: ₹65.3 bn (+18% YoY, +24% QoQ). EBITDA: ₹21.3 bn (+30% YoY, +53% QoQ); margin at 32.6% (+310 bps YoY, +630 bps QoQ). Net profit (excl. exceptionals): ₹13.9 bn (+18% YoY, +36% QoQ). 📄 Report: Click Here (https://tradeboxfintech.s3.ap-south-1.amazonaws.com/ServiceProviderPosts/Ghansham%20Joshi%20Prop%20of%20GJ%27s%20Techno%20Funda-%28gjstechnofunda%40gmail.com%29/19g6qmb65jzdc-gjstechnofunda%40gmail.com-%28recommendationPDF%29-Report%20-%2027%20May%202025%20-%20Zydus%20Lifesciences%20Ltd.pdf) Recommended By: Ghansham Joshi Prop of GJ's Techno Funda (SEBI-Registered Research Analyst) 📦 Checkout my Plans: Click Here (https://tradeboxlive.com/view/serviceprovider/67ea2d5329fa973560d293d4/services) 🔗 Link: https://docs.google.com/document/d/1B86zIUU7xyw3kaaM-zUh77jDvOOtlG8N043Wgw-oynI/edit?usp=sharing ⚠️ Disclaimer: https://tradeboxlive.com/documents/disclaimer